Clinical Trial Update: Benfotiamine Effect on Advanced Glycation End Products(AGEs) and Soluble Receptor for AGEs(sRAGE) in Diabetes Mellitus. [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of benfotiamine on advanced glycation end products (AGEs) and soluble receptor for AGEs (sRAGE) in individuals w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Benfotiamine (benfotiamine)

Snippet

Sponsor: Universidad de Guanajuato | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED